Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-09

Clinical Trial Update: Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) [NA]

View source ↗

Summary

This entry describes the TARGET-PA trial evaluating an aldosterone-hybrid steroid to guide curable treatment of primary aldosteronism; the study status is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aldosterone-hybrid Steroid

Snippet

Sponsor: Changi General Hospital | Conditions: Hyperaldosteronism; Primary, Primary Aldosteronism Due to Aldosterone Producing Adenoma | NA | Status: NOT_YET_RECRUITING